| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
LB Pharmaceuticals Inc (NASDAQ:LBRX) IPO will take place September, 11 on the NASDAQ exchange under the ticker LBRX.
The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on March 10, 2026.
See also: Benzinga IPO Calendar
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases.
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: LBRX
